Genomic evidence for reinfection with SARS-CoV-2: a case study

@article{Tillett2020GenomicEF,
  title={Genomic evidence for reinfection with SARS-CoV-2: a case study},
  author={Richard L. Tillett and Joel R. Sevinsky and Paul D. Hartley and Heather Kerwin and Natalie M Crawford and Andrew J. Gorzalski and Chris Laverdure and Subhash C. Verma and Cyprian C. Rossetto and David K. Jackson and Megan J Farrell and Stephanie Van Hooser and Mark Pandori},
  journal={The Lancet. Infectious Diseases},
  year={2020},
  volume={21},
  pages={52 - 58}
}
Background The degree of protective immunity conferred by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently unknown. As such, the possibility of reinfection with SARS-CoV-2 is not well understood. We describe an investigation of two instances of SARS-CoV-2 infection in the same individual. Methods A 25-year-old man who was a resident of Washoe County in the US state of Nevada presented to health authorities on two occasions with symptoms of viral… Expand

Figures and Tables from this paper

Symptomatic SARS-CoV-2 Reinfection in a Healthy Healthcare Worker in Italy Confirmed by Whole-Genome Sequencing
This study describes a case of SARS-CoV-2 reinfection confirmed by whole-genome sequencing in a healthy physician who had been working in a COVID-19 hospital in Italy since the beginning of theExpand
Case report: change of dominant strain during dual SARS-CoV-2 infection
TLDR
The findings suggest that the patient was infected by two genetically distinct SARS-CoV-2 strains at the same time, and one of the possible explanations is that the second infection was hospital-acquired. Expand
Change of dominant strain during dual SARS-CoV-2 infection
TLDR
The findings suggest that the patient was infected by two genetically distinct SARS-CoV-2 strains at the same time, one of the possible explanations is that the second infection occurred in the hospital. Expand
Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfection
TLDR
A case of SARS-CoV-2 reinfection 6 months after the first infection in a young healthy female physician, indicating that the first episode elicited cellular memory responses, and rapid decline of neutralizing antibodies may put medical personnel at risk of reinfections. Expand
Reinfection of SARS-CoV-2 – analysis of 23 cases from the literature
TLDR
A better understanding of immunity to SARS-CoV-2, necessary to assess the probability of a second infection and the durability of protection conferred by vaccination, is warranted. Expand
COVID-19 reinfection: A Rapid Systematic Review of Case Reports and Case Series
TLDR
It is shown that reinfection with different strains is possible and some cases may experience more severe infections with the second episode of COVID-19, suggesting the need for longer term transmission mitigation efforts. Expand
Antibodies to SARS-CoV-2 are associated with protection against reinfection
TLDR
Positive baseline anti-spike antibodies were associated with lower rates of PCR-positivity (with or without symptoms) and further work is required to determine the long-term duration and correlates of post-infection immunity. Expand
COVID-19 Reinfection and its Diagnostic Approach
TLDR
This is a review article to study the diagnostic approach and diagnostic criteria of reinfection after few cases were studied so far with Indian Scenario and the whole genome sequencing done in these patients provide valuable evidence for reinfections. Expand
Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran
  • M. Salehi-Vaziri, T. Jalali, +6 authors A. Ramezani
  • Medicine
  • European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
  • 2021
TLDR
The data supports clear warning of SARS-CoV-2 continuous circulation potency among the populations in spite of herd immunity either with natural infection or vaccination. Expand
Dynamics of a dual SARS-CoV-2 strain co-infection on a prolonged viral shedding COVID-19 case: insights into clinical severity and disease duration
TLDR
The early-on dynamic co-infection was the probable cause for the severity of COVID-19 in this otherwise healthy young patient, and for her prolonged SARS-CoV-2 shedding profile. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 33 REFERENCES
Evolution of viral quasispecies during SARS-CoV-2 infection
Abstract Objectives Studies are needed to better understand the genomic evolution of the recently emerged severe acute respiratoryExpand
COVID-19 Re-Infection by a Phylogenetically Distinct SARS-CoV-2 Variant, First Confirmed Event in South America.
TLDR
A patient with two COVID-19 events presented two different SARS-CoV-2 variants on each event, confirming reinfection, and this phenomenon is still considered rare. Expand
COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing
  • K. To, I. Hung, +17 authors K. Yuen
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
TLDR
The results suggest SARS-CoV-2 may continue to circulate among the human populations despite herd immunity due to natural infection or vaccination, and further studies of patients with re-infection will shed light on protective correlates important for vaccine design. Expand
Genomic surveillance revealed prevalence of unique SARS-CoV-2 variants bearing mutation in the RdRp gene among Nevada patients.
TLDR
The study reports the finding of a novel variant in the nsp12 (RdRp-RNA dependent RNA Polymerase) protein at residue 323, present in the original isolate of SARS-CoV-2 (Wuhan-1), suggesting for a founder effect. Expand
Human neutralizing antibodies elicited by SARS-CoV-2 infection
TLDR
In a study of antibodies isolated from patients infected with SARS-CoV-2, antibodies that potently neutralized the virus competed with angiotensin-converting enzyme 2 for binding to the receptor-binding domain of the viral spike protein, suggesting that antibodies that disrupt this interaction could be developed to treat Sars-Cov-2 infection. Expand
Geographic and Genomic Distribution of SARS-CoV-2 Mutations
TLDR
The analysis may facilitate custom-designed antiviral strategies based on the molecular specificities of SARS-CoV-2 in different patients and geographical locations and shows the prevalence of single nucleotide transitions as the major mutational type across the world. Expand
Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
TLDR
It is demonstrated that human macrophages can be infected by SARS-CoV as a result of IgG-mediated ADE and indicates that this infection route requires signaling pathways activated downstream of binding to FcγRII receptors. Expand
A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease
TLDR
While studies of SARS-CoV-2 are necessary to determine immune responses to it, evidence from other coronaviruses can provide clues and guide future research. Expand
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant
TLDR
The findings suggest that the virus is evolving and European, North American and Asian strains might coexist, each of them characterized by a different mutation pattern. Expand
Phylogenetic Analysis of SARS-CoV-2 Genomes in Turkey
TLDR
A phylogenetic analysis of the first thirty SARS-CoV-2 genomes isolated and sequenced in Turkey suggests that the first introduction of the virus to the country is earlier than the first reported case of infection and reveals a hub for the inland transmission. Expand
...
1
2
3
4
...